Results for tag: "Efient"

Efient is a cardiovascular drug used to treat coronary artery disease. It is a type of antiplatelet drug, which works by preventing the formation of blood clots in the arteries. It is used to reduce the risk of heart attack and stroke in people with coronary artery disease. It is also used to reduce the risk of recurrent heart attack and stroke in people who have already had a heart attack or stroke. Efient is usually taken in combination with other medications, such as aspirin and statins. The Efient market is a rapidly growing segment of the cardiovascular drug market. It is driven by the increasing prevalence of coronary artery disease, as well as the need for more effective treatments. The market is expected to continue to grow in the coming years, as more people are diagnosed with coronary artery disease and the need for more effective treatments increases. Some of the major companies in the Efient market include Pfizer, AstraZeneca, and Daiichi Sankyo. These companies are involved in the development, manufacture, and marketing of Efient. Other companies in the market include Sanofi, Merck, and Bristol-Myers Squibb. Show Less Read more